JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2004) 180, 125-133       DOI: 10.1677/joe.0.1800125
© 2004 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, M
Right arrow Articles by Nakajin, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, M
Right arrow Articles by Nakajin, S
Journal of Endocrinology, Vol 180, Issue 1, 125-133
Copyright © 2004 by Society for Endocrinology


Articles

Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R

M Watanabe and S Nakajin


A number of conditions related to sex-reversal in boys and men and precocious puberty in girls are caused by estrogen-secreting adrenal tumors. In these tumors, cytochrome P450 aromatase (aromatase) that is encoded in the CYP19 gene is expressed at high levels. To investigate the molecular mechanism of aromatase expression in these adrenal tumors, we characterized the activity, gene transcript and genomic promoter region of aromatase in the human adrenocortical carcinoma cell line H295R. Aromatase activity and the transcript of the CYP19 gene were highly up-regulated by forskolin, but not by dexamethasone. The results from exon I-specific reverse transcriptase (RT)-PCR and the transfection of reporter constructs suggested that promoter I.3 and promoter II were activated in H295R. Deletion and mutation analysis suggested that cAMP response element-like sequence (CLS) and steroidogenic factor-1 (SF-1) motif, were critical for the activation of promoter II. The results of this work should provide the basis for the molecular analysis of aromatase expression in adrenocortical cells.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
F. Moreau, H. Mittre, A. Benhaim, C. Bois, J. Bertherat, S. Carreau, and Y. Reznik
Aromatase expression in the normal human adult adrenal and in adrenocortical tumors: biochemical, immunohistochemical, and molecular studies
Eur. J. Endocrinol., January 1, 2009; 160(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. S. Baquedano, N. Saraco, E. Berensztein, C. Pepe, M. Bianchini, E. Levy, J. Goni, M. A. Rivarola, and A. Belgorosky
Identification and Developmental Changes of Aromatase and Estrogen Receptor Expression in Prepubertal and Pubertal Human Adrenal Tissues
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2215 - 2222.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. T. Sanderson
The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals
Toxicol. Sci., November 1, 2006; 94(1): 3 - 21.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Watanabe, M. Noda, and S. Nakajin
Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells
J. Endocrinol., January 1, 2006; 188(1): 59 - 68.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
D Montanaro, M Maggiolini, A G Recchia, R Sirianni, S Aquila, L Barzon, F Fallo, S Ando, and V Pezzi
Antiestrogens upregulate estrogen receptor {beta} expression and inhibit adrenocortical H295R cell proliferation
J. Mol. Endocrinol., October 1, 2005; 35(2): 245 - 256.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Watanabe, S. Ohno, and S. Nakajin
Forskolin and dexamethasone synergistically induce aromatase (CYP19) expression in the human osteoblastic cell line SV-HFO
Eur. J. Endocrinol., April 1, 2005; 152(4): 619 - 624.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. T. Sanderson, J. Hordijk, M. S. Denison, M. F. Springsteel, M. H. Nantz, and M. van den Berg
Induction and Inhibition of Aromatase (CYP19) Activity by Natural and Synthetic Flavonoid Compounds in H295R Human Adrenocortical Carcinoma Cells
Toxicol. Sci., November 1, 2004; 82(1): 70 - 79.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Endocrinology.